2,3,4,8,9,10-HEXAHYDRO-3,9-BIS(PHENYLMETHYL)-1,3-OXAZINO(5',6':5,6)NAPHTH(1,2-E)(1,3)OXAZINE
UNII 7I0QE1VX3P
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,3,4,8,9,10-hexahydro-3,9-bis(phenylmethyl)-1,3-oxazino(5',6':5,6)naphth(1,2-e)(1,3)oxazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7I0QE1VX3P.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 58671-21-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H26N2O2 ZQMYHQFLCMONLU-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,3,4,8,9,10-hexahydro-3,9-bis(phenylmethyl)-1,3-oxazino(5',6':5,6)naphth(1,2-e)(1,3)oxazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.